Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 222

1.

Quantitative cardiovascular magnetic resonance: extracellular volume, native T1 and 18F-FDG PET/CMR imaging in patients after revascularized myocardial infarction and association with markers of myocardial damage and systemic inflammation.

Kunze KP, Dirschinger RJ, Kossmann H, Hanus F, Ibrahim T, Laugwitz KL, Schwaiger M, Rischpler C, Nekolla SG.

J Cardiovasc Magn Reson. 2018 May 24;20(1):33. doi: 10.1186/s12968-018-0454-y.

2.

Motion-corrected whole-heart PET-MR for the simultaneous visualisation of coronary artery integrity and myocardial viability: an initial clinical validation.

Munoz C, Kunze KP, Neji R, Vitadello T, Rischpler C, Botnar RM, Nekolla SG, Prieto C.

Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1975-1986. doi: 10.1007/s00259-018-4047-7. Epub 2018 May 12.

3.

Hybrid cardiac imaging using PET/MRI: a joint position statement by the European Society of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine (EANM).

Nensa F, Bamberg F, Rischpler C, Menezes L, Poeppel TD, la Fougère C, Beitzke D, Rasul S, Loewe C, Nikolaou K, Bucerius J, Kjaer A, Gutberlet M, Prakken NH, Vliegenthart R, Slart RHJA, Nekolla SG, Lassen ML, Pichler BJ, Schlosser T, Jacquier A, Quick HH, Schäfers M, Hacker M; European Society of Cardiovascular Radiology (ESCR); European Association of Nuclear Medicine (EANM) Cardiovascular Committee.

Eur Radiol. 2018 Oct;28(10):4086-4101. doi: 10.1007/s00330-017-5008-4. Epub 2018 May 2.

4.

Myocardial perfusion quantification using simultaneously acquired 13 NH3 -ammonia PET and dynamic contrast-enhanced MRI in patients at rest and stress.

Kunze KP, Nekolla SG, Rischpler C, Zhang SH, Hayes C, Langwieser N, Ibrahim T, Laugwitz KL, Schwaiger M.

Magn Reson Med. 2018 Apr 19. doi: 10.1002/mrm.27213. [Epub ahead of print]

PMID:
29672922
5.

Treatment of carcinoma in situ of the urinary bladder with an alpha-emitter immunoconjugate targeting the epidermal growth factor receptor: a pilot study.

Autenrieth ME, Seidl C, Bruchertseifer F, Horn T, Kurtz F, Feuerecker B, D'Alessandria C, Pfob C, Nekolla S, Apostolidis C, Mirzadeh S, Gschwend JE, Schwaiger M, Scheidhauer K, Morgenstern A.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1364-1371. doi: 10.1007/s00259-018-4003-6. Epub 2018 Apr 11.

PMID:
29644393
6.

Multi institutional quantitative phantom study of yttrium-90 PET in PET/MRI: the MR-QUEST study.

Maughan NM, Eldib M, Faul D, Conti M, Elschot M, Knešaurek K, Leek F, Townsend D, DiFilippo FP, Jackson K, Nekolla SG, Lukas M, Tapner M, Parikh PJ, Laforest R.

EJNMMI Phys. 2018 Apr 4;5(1):7. doi: 10.1186/s40658-018-0206-y.

7.

Lost in quantification…: The influence of different software packages on flow quantification measures.

Rischpler C, Nekolla SG.

J Nucl Cardiol. 2018 Jan 16. doi: 10.1007/s12350-017-1159-6. [Epub ahead of print] No abstract available.

PMID:
29340987
8.

CT-based SPECT attenuation correction and assessment of infarct size: results from a cardiac phantom study.

Kroiss AS, Nekolla SG, Dobrozemsky G, Grubinger T, Shulkin BL, Schwaiger M.

Ann Nucl Med. 2017 Dec;31(10):764-772. doi: 10.1007/s12149-017-1211-2. Epub 2017 Sep 21.

PMID:
28936780
9.

In-depth Characterization of a TCR-specific Tracer for Sensitive Detection of Tumor-directed Transgenic T Cells by Immuno-PET.

Yusufi N, Mall S, Bianchi HO, Steiger K, Reder S, Klar R, Audehm S, Mustafa M, Nekolla S, Peschel C, Schwaiger M, Krackhardt AM, D'Alessandria C.

Theranostics. 2017 Jun 15;7(9):2402-2416. doi: 10.7150/thno.17994. eCollection 2017.

10.

Segmentation of Skeleton and Organs in Whole-Body CT Images via Iterative Trilateration.

Bieth M, Peter L, Nekolla SG, Eiber M, Langs G, Schwaiger M, Menze B.

IEEE Trans Med Imaging. 2017 Nov;36(11):2276-2286. doi: 10.1109/TMI.2017.2720261. Epub 2017 Jun 27.

PMID:
28678702
11.

Exploring New Multimodal Quantitative Imaging Indices for the Assessment of Osseous Tumor Burden in Prostate Cancer Using 68Ga-PSMA PET/CT.

Bieth M, Krönke M, Tauber R, Dahlbender M, Retz M, Nekolla SG, Menze B, Maurer T, Eiber M, Schwaiger M.

J Nucl Med. 2017 Oct;58(10):1632-1637. doi: 10.2967/jnumed.116.189050. Epub 2017 May 25.

PMID:
28546330
12.

Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using 111In-tilmanocept.

Varasteh Z, Hyafil F, Anizan N, Diallo D, Aid-Launais R, Mohanta S, Li Y, Braeuer M, Steiger K, Vigne J, Qin Z, Nekolla SG, Fabre JE, Döring Y, Le Guludec D, Habenicht A, Vera DR, Schwaiger M.

EJNMMI Res. 2017 Dec;7(1):40. doi: 10.1186/s13550-017-0287-y. Epub 2017 May 3.

13.

A multi-centre evaluation of eleven clinically feasible brain PET/MRI attenuation correction techniques using a large cohort of patients.

Ladefoged CN, Law I, Anazodo U, St Lawrence K, Izquierdo-Garcia D, Catana C, Burgos N, Cardoso MJ, Ourselin S, Hutton B, Mérida I, Costes N, Hammers A, Benoit D, Holm S, Juttukonda M, An H, Cabello J, Lukas M, Nekolla S, Ziegler S, Fenchel M, Jakoby B, Casey ME, Benzinger T, Højgaard L, Hansen AE, Andersen FL.

Neuroimage. 2017 Feb 15;147:346-359. doi: 10.1016/j.neuroimage.2016.12.010. Epub 2016 Dec 14.

14.

Cardiovascular preclinical imaging.

Nekolla SG, Rischpler C, Paschali A, Anagnostopoulos C.

Q J Nucl Med Mol Imaging. 2017 Mar;61(1):48-59. doi: 10.23736/S1824-4785.16.02960-5. Epub 2016 Dec 16. Review.

15.

One Coin, No Need to Flip: Shared PET Targets in Cancer and Coronary Artery Disease.

Paschali AN, Nekolla SG, Evangelou K, Cook GJ, Anagnostopoulos CD.

AJR Am J Roentgenol. 2017 Feb;208(2):434-445. doi: 10.2214/AJR.16.16599. Epub 2016 Nov 29. Review.

PMID:
27897437
16.

Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer 68Ga-Pentixafor for PET.

Hyafil F, Pelisek J, Laitinen I, Schottelius M, Mohring M, Döring Y, van der Vorst EP, Kallmayer M, Steiger K, Poschenrieder A, Notni J, Fischer J, Baumgartner C, Rischpler C, Nekolla SG, Weber C, Eckstein HH, Wester HJ, Schwaiger M.

J Nucl Med. 2017 Mar;58(3):499-506. doi: 10.2967/jnumed.116.179663. Epub 2016 Oct 27.

17.

Effect of blood activity on dosimetric calculations for radiopharmaceuticals.

Zvereva A, Petoussi-Henss N, Li WB, Schlattl H, Oeh U, Zankl M, Graner FP, Hoeschen C, Nekolla SG, Parodi K, Schwaiger M.

Phys Med Biol. 2016 Nov 7;61(21):7688-7703. Epub 2016 Oct 14.

PMID:
27740942
18.

Cardiac PET/MRI enters the clinical arena! Finally….

Rischpler C, Langwieser N, Nekolla SG.

J Nucl Cardiol. 2018 Jun;25(3):795-796. doi: 10.1007/s12350-016-0671-4. Epub 2016 Sep 23. No abstract available.

PMID:
27663252
19.

PET/MR: Yet another Tesla?

Schwaiger M, Kunze K, Rischpler C, Nekolla SG.

J Nucl Cardiol. 2017 Jun;24(3):1019-1031. doi: 10.1007/s12350-016-0665-2. Epub 2016 Sep 22. Review.

PMID:
27659455
20.

PET/MR Imaging in Heart Disease.

Rischpler C, Nekolla SG.

PET Clin. 2016 Oct;11(4):465-77. doi: 10.1016/j.cpet.2016.05.006. Epub 2016 Jul 5. Review.

PMID:
27593250

Supplemental Content

Loading ...
Support Center